These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1361829

  • 1. Low calcium (2.5 mEq/l) and high calcium (3.5 mEq/l) dialysate in peritoneal dialysis patients.
    Wadhwa NK, Howell N, Suh H, Cabralda T.
    Adv Perit Dial; 1992; 8():385-8. PubMed ID: 1361829
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis.
    Banalagay E, Bernardini J, Holley J, Chen T, Piraino B.
    Adv Perit Dial; 1993; 9():280-3. PubMed ID: 8105943
    [Abstract] [Full Text] [Related]

  • 3. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P, Ortega O, Gutiérrez M, Muñoz M, Hilara L, Oliet A, Rodríguez I, Giménez E, Vigil A.
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [Abstract] [Full Text] [Related]

  • 4. CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study.
    Honkanen E, Kala AR, Grönhagen-Riska C, Ikäheimo R.
    Adv Perit Dial; 1992; 8():356-61. PubMed ID: 1361822
    [Abstract] [Full Text] [Related]

  • 5. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
    Cheng IK, Lu HB, Chan CY, Cheng SW, Robinson JD, Tam SC, Lo WK, Cheung WC.
    Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
    [Abstract] [Full Text] [Related]

  • 6. Calcium mass transfer in peritoneal dialysis patients using 2.5 mEq/l calcium dialysate.
    Piraino B, Bernardini J, Holley J, Johnston JR, Perlmutter JA, Martis L.
    Clin Nephrol; 1992 Jan; 37(1):48-51. PubMed ID: 1541065
    [Abstract] [Full Text] [Related]

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 8. Pulse intravenous calcitriol therapy of secondary hyperparathyroidism in peritoneal dialysis patients.
    Wadhwa NK, Suh H, Howell N, Cabralda T, Sokunbi D, Solomon M.
    Adv Perit Dial; 1993 Nov; 9():260-3. PubMed ID: 8105939
    [Abstract] [Full Text] [Related]

  • 9. Satisfactory control of secondary hyperparathyroidism with low-calcium dialysate in patients not receiving vitamin D.
    Teruel JL, Nitvarro JF, Marcen R, Aguilera A, Tato A, Ottuño J.
    Miner Electrolyte Metab; 1997 Nov; 23(1):19-24. PubMed ID: 9058365
    [Abstract] [Full Text] [Related]

  • 10. Successful use of zero calcium dialysate to treat hypercalcemia in a postsurgical peritoneal dialysis patient.
    Mars RL.
    Adv Perit Dial; 1993 Nov; 9():284-7. PubMed ID: 8105944
    [Abstract] [Full Text] [Related]

  • 11. Is 2.5 mEq/L the optimal calcium concentration of dialysate in the use of sevelamer hydrochloride? A study of the dialysate calcium concentration recommended by K/DOQI guidelines.
    Izumi M, Shirai K, Ito K, Miyamoto T, Matsumoto A, Takenaka Y, Nakagawa K, Yamanashi T, Takamitsu Y, Nakanish T.
    Ther Apher Dial; 2005 Feb; 9(1):24-31. PubMed ID: 15828902
    [Abstract] [Full Text] [Related]

  • 12. Length of interdialytic interval influences serum calcium and phosphorus concentrations.
    Sigrist MK, Devlin L, Taal MW, Fluck RJ, McIntyre CW.
    Nephrol Dial Transplant; 2005 Aug; 20(8):1643-6. PubMed ID: 15870223
    [Abstract] [Full Text] [Related]

  • 13. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.
    Hwang JC, Chen CA, Wang CT, Chen HC.
    Ren Fail; 2008 Aug; 30(10):943-51. PubMed ID: 19016144
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of dialysate calcium concentrations on parathyroid hormone and calcium balance during a single dialysis session using bicarbonate hemodialysis: a crossover clinical trial.
    Basile C, Libutti P, Di Turo AL, Vernaglione L, Casucci F, Losurdo N, Teutonico A, Lomonte C.
    Am J Kidney Dis; 2012 Jan; 59(1):92-101. PubMed ID: 22000728
    [Abstract] [Full Text] [Related]

  • 16. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
    Spasovski G, Gelev S, Masin-Spasovska J, Selim G, Sikole A, Vanholder R.
    Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363
    [Abstract] [Full Text] [Related]

  • 17. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ, van der Kuy A, ter Wee PM, van Boven WP.
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [Abstract] [Full Text] [Related]

  • 18. Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels.
    Montenegro J, Saracho R, González O, Moina I, Martínez I.
    Clin Nephrol; 1997 Dec; 48(6):359-63. PubMed ID: 9438094
    [Abstract] [Full Text] [Related]

  • 19. Parathyroid hormone during maintenance dialysis: influence of low calcium dialysate, plasma albumin and age.
    Heaf JG, Løkkegård H.
    J Nephrol; 1998 Dec; 11(4):203-10. PubMed ID: 9702872
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.